e-learning
resources
Copenhagen 2005
Monday 19.09.2005
COPD - treatment II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Methylprednisolone can improve isolated nocturnal hypoxemia in stable COPD patients
B. Sposato, G. Migliorini, S. Mariotta, A. Ricci, E. Canneti, L. Mancini, A. Grieco, P. Bruno, R. Martinelli, C. Franco (Grosseto, Rome, Italy)
Source:
Annual Congress 2005 - COPD - treatment II
Session:
COPD - treatment II
Session type:
Thematic Poster Session
Number:
1937
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Sposato, G. Migliorini, S. Mariotta, A. Ricci, E. Canneti, L. Mancini, A. Grieco, P. Bruno, R. Martinelli, C. Franco (Grosseto, Rome, Italy). Methylprednisolone can improve isolated nocturnal hypoxemia in stable COPD patients. Eur Respir J 2005; 26: Suppl. 49, 1937
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Montelukast can improve isolated nocturnal hypoxemia in stable COPD patients with positive reversibility test
Source: Eur Respir J 2006; 28: Suppl. 50, 427s
Year: 2006
How to prevent exercise-induced hypoxemia in patients with severe COPD?
Source: Annual Congress 2008 - Use of noninvasive ventilation in various conditions
Year: 2008
Predictors of nocturnal desaturation in COPD patients with mild daytime hypoxaemia
Source: Eur Respir J 2003; 22: Suppl. 45, 468s
Year: 2003
Dyspnea and hypoxemia in COPD and CHF patients is more severe and prolonged after acetate hemodialysis
Source: Annual Congress 2008 - Exercise: system responses
Year: 2008
The reversibility of hypoxemia in OSA patients is related to CPAP therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 112s
Year: 2005
How to provide NIV in the COPD patient with chronic stable hypercapnia
Source: Sleep and Breathing Conference 2017
Year: 2017
CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD
Source: Eur Respir J 2010; 35: 132-137
Year: 2010
Domiciliary high-flow in patients with severe COPD and chronic hypoxic failure: In whom can we reduce exacerbations.
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
Nocturnal hypercapnia and oxygen therapy in COPD patients
Source: Annual Congress 2008 - Pathophysiology of COPD
Year: 2008
Ward-based non-invasive ventilation can be used to successfully treat severely acidotic patients with an exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Noninvasive mechanical ventilation in the acute setting
Year: 2008
Are there any patient-features to predict long-term benefit from noninvasive intermittent positive pressure ventilation (nIPPV) in patients with severe stable chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 403s
Year: 2001
Predictors of poor outcome in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) receiving noninvasive positive pressure ventilation (NPPV
Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure
Year: 2015
Effects of long-acting bronchodilators on changes of inspiratory capacity by hyperventilation in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 430s
Year: 2006
Outcome of COPD patients with mild daytime hypoxaemia with or without sleep-related oxygen desaturation
Source: Eur Respir J 2001; 17: 848-855
Year: 2001
Do patients with recurrent exacerbations of COPD requiring NIV receive higher pressures than those that are NIV naive?
Source: Annual Congress 2013 –New evidence for NIV in the acute setting
Year: 2013
Domiciliary ambulatory oxygen is not beneficial in patients with COPD and mild resting hypoxaemia
Source: Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy
Year: 2010
Effects of reduced lung volumes and age on oxyhemoglobin nocturnal desaturation in obstructive sleep apnea patients before and after CPAP treatment
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II
Year: 2011
Clinical significance of episodic nocturnal hypercapnia and its treatment with non-invasive positive pressur ventilation in patients with stable advanced chronic obstructive pulmonary disease
Source: International Congress 2018 – New tools for managing respiratory failure
Year: 2018
Usefulness of ventilatory response to hypoxemia and hypercapnia to detect oxygen-induced nocturnal hypercapnia in stable COPD patients
Source: Annual Congress 2005 - Control of breathing
Year: 2005
Prevalence,determinants and impact of nocturnal hypoxemia in COPD patients not candidates for domiciliary oxygen therapy
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept